ArticleBMC pediatrics2016
Evaluation of the revised Nipissing District Developmental Screening (NDDS) tool for use in general population samples of infants and children.
Article in BMC pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Developmental screening at 18 months using the Nipissing District Developmental Screen.Paediatrics & child health · 2025Article
- Brief multidimensional screening tools for young children's mental health and development for administration by primary care providers: a scoping review.BMC primary care · 2025Article
- Screening for developmental delay at 18 months using the Infant Toddler Checklist: A validation study.PloS one · 2025Article
- Program evaluation of a pilot mobile developmental outreach clinic for autism spectrum disorder in Ontario.BMC health services research · 2022Article
- Interim schedule for pregnant women and children during the COVID-19 pandemic.Canadian family physician Medecin de famille canadien · 2020Article
- Early detection for autism spectrum disorder in young children.Paediatrics & child health · 2019Review
- Recommendations on screening for developmental delay.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2016Review
- Effectiveness of Enhanced Developmental Screening at 18 Months to Identify Developmental Delays.Journal of developmental and behavioral pediatrics : JDBPArticle
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is widespread interest in identification of developmental delay in the first six years of life. This requires, however, a reliable and valid measure for screening. In Ontario, the 18-month enhanced well-baby visit includes province-wide administration of a parent-reported survey, the Nipissing District Developmental Screening (NDDS) tool, to facilitate early identification of delay. Yet, at present the psychometric properties of the NDDS are largely unknown.
method812 children and their families were recruited from the community. Parents (most often mothers) completed the NDDS. A sub-sample (n = 111) of parents completed the NDDS again within a two-week period to assess test-retest reliability. For children 3 or younger, the criterion measure was the Bayley Scales of Infant Development, 3rd edition; for older children, a battery of other measures was used. All criterion measures were administered by trained assessors. Mild and severe delays were identified based on both published cut-points and on the distribution of raw scores. Sensitivity, specificity, positive and negative predictive values were calculated to assess agreement between tests.
resultsTest-retest reliability was modest (Spearman's rho = .62, p < 001). Regardless of the age of the child, the definition of delay (mild versus severe), or the cut-point used on the NDDS, sensitivities (from 29 to 68 %) and specificities (from 58 to 88 %) were poor to moderate.
conclusionThe modest test-retest results, coupled with the generally poor observed agreement with criterion measures, suggests the NDDS should not be used on its own for identification of developmental delay in community or population-based settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.